BackX4 Pharmaceuticals Overview
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Target Price

Analysts' average 12-month price target for X4 Pharmaceuticals is $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.04

Average Target Price

$11.50184.7% upside

2 analysts in the last 4 months

High: $12 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-10Wells Fargo$11172.3% upsideOpen
2026-06-02Leerink PartnersThomas Smith$12197% upsideOpen
2026-03-09Guggenheim$12197% upsideOpen
2025-12-05Stifel NicolausJames Condulis$10147.5% upsideOpen
2025-11-05Stifel NicolausStephen Willey$7.585.6% upsideOpen
2025-08-29Stifel NicolausStephen Willey$9122.8% upsideOpen
2025-08-13H.C. WainwrightSwayampakula Ramakanth$3.513.4% downsideOpen
2022-12-22Cantor Fitzgerald$325.7% downsideOpen
2022-12-11Piper SandlerEdward Tenthoff$325.7% downsideOpen
2022-11-30H.C. Wainwright$523.8% upsideOpen

X4 Pharmaceuticals (XFOR) FAQ

As of the most recent data, XFOR shows a target price of $12. Scroll down for historical charts and peer comparison views.

If X4 Pharmaceuticals moved to the average analyst target of $12, shares would be roughly 184.7% higher than $4.04. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of X4 Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has X4 Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $12) with ownership activity and broader fundamentals.

X4 Pharmaceuticals's target price is $12; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.